Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The study will evaluate the within-subject variability of 20mg ER torsemide as compared to 20mg IR torsemide (Demadex) in fully replicate double-crossover trial in healthy volunteers, who are consuming a high-salt diet (300 mmol/day). The study will also evaluate the effects of ER torsemide and IR torsemide on 24h sodium excretion and total urinary excretion.
Epistemonikos ID: 4af3e6b9c5a4ce363f64ded956e68d8c16d512e9
First added on: May 20, 2024